Let's not forget that Elite has had this two bead technology since around 2009... they have been advertising it within their pipeline for many many years, and they got the patent... so "big pharma" definitely know about it, however, no one has shown interest for a few reasons... if this technology works, the preliminary results would be out already, but it has been more than 10 years and nothing
you can go through the history of Elite to see how they just play around with their pipeline and their two bead technology hasn't proved its potential after 10 years.
And the technology had great potential! but Elite got distracted with their friend Mikah doing all sorts of dodgy purchases/sales, and here they are with a value of $0.11 ;)
Not quite true there. NH said that if a reformulation did not show significant progress that he would appeal to the FDA at the highest level for a labeling claim. That may not be needed now.
Also IF a renewed testing of SequestOx shows similar results to the pilot study recently done and is acceptable to the FDA Elite will want to get a marketed product out there to show proof of concept. Once a marketed product is out there the ADF price tag goes up exponentially.